News | SummitMD

Extended BEST trial offers insight into murky dispute over optimal long-term revasc strategy in MVCAD

10-year follow-up of BEST study from 2015 latest to show near ‘clinical equipoise’ between contemporary PCI versus CABG for multivessel disease

News | SummitMD

TAVI noninferior to surgery for elderly, severe AS patients at moderate operative risk: UK TAVI

Study finds TAVI noninferior to SAVR for all-cause mortality at 1-year in patients with severe, symptomatic AS over 70 years at moderately increased surgical risk

News | SummitMD

Recap: Takeaways from 2021 ACC/AHA/SCAI guideline for coronary artery revascularization

Updated American guidance on coronary intervention advocates multidisciplinary heart teams for revascularization decisions, leads to momentary rift between cardiac specialties

News | SummitMD

No difference between PCI-OMT for mortality, HF-hospitalization in severe LV dysfunction: REVIVED-BCIS2

Coronary revascularization fails to meaningfully lower mortality in severe ischemic cardiomyopathy over medical therapy alone

News | SummitMD

POST-PCI raises red flags for routine functional testing in high-risk PCI patients

2-year follow-up of PCI patients at high anatomical, clinical risk showed no survival benefits with surveillance testing over standard care

News | SummitMD

‘First big step’ for xenotransplantation inches forward elusive future of heart transplantation

Short-term success of 3 recent pig-to-human cardiac transplantations reignites drive to develop new treatment options for patients with heart failure, experts say

News | SummitMD

Time to halt routine, post-TAVR oral anticoagulant therapy, CT scans: insights from the ADAPT-TAVR trial

Study finds no association between subclinical leaflet thrombosis and neurological dysfunction, trend for lower SLT with DOAC compared to DAPT